key: cord-0896487-69zp2kw4
authors: Chung, Jennifer E.; Lee, Andrew R.; Guerriero, Réjean M.; Reynolds, Margaret M.
title: A case of papilledema associated with COVID-19 multisystem inflammatory syndrome in children (MIS-C)
date: 2021-08-25
journal: Can J Ophthalmol
DOI: 10.1016/j.jcjo.2021.08.011
sha: 73713d3d02f98a4c0ca3fec458cd57691cee1d38
doc_id: 896487
cord_uid: 69zp2kw4

nan

Multisystem inflammatory syndrome in children (MIS-C), also called pediatric inflammatory multisystem syndrome, is characterized by a wide range of symptoms and can present a diagnostic challenge given its myriad presentations. On top of the more well-known inflammatory manifestations of MIS-C, recent reports have also surfaced of MIS-C causing increased intracranial pressure. 1,2 MIS-C can present similarly to other systemic inflammatory disorders like Kawasaki disease and can be especially difficult to distinguish from Kawasaki if a Kawasaki-like presentation is accompanied by a positive test for COVID-19. 3 2 In adults, ocular manifestations of COVID-19 include nonspecific symptoms such as conjunctival hyperemia, chemosis, epiphora, and increased secretions. 4 However, there is a relative paucity of literature regarding ocular manifestations of COVID-19 in children relative to adults. Some documented pediatric symptoms include a similar conjunctivitis presentation, along with increased conjunctival discharge, ocular pain, and eyelid swelling, 5 but pediatric MIS-C is far from completely characterized.

Here, we present a pediatric patient who developed bilateral papilledema and abducens nerve palsy in the setting of MIS-C to highlight the potential increased intracranial hypertension and neurologic complications of this inflammatory condition. Institutional Review Board approval was obtained at the Washington University in St. Louis, and consent was provided by the patient's parents.

A 12-year-old male with no past medical history and past ocular history of myopia, astigmatism, and mild amblyopia of the right eye presented to our institution in May 2020 for fever, vomiting, and diarrhea. These symptoms were accompanied by headache, fatigue, dysgeusia, photophobia, and 2 episodes of epistaxis on the day of presentation. The patient's father had experienced similar symptoms and anosmia following recent domestic travel but was not tested for COVID-19. The patient did not have any respiratory or ophthalmic symptoms at presentation. A rapid streptococcal antigen and COVID-19 RT-PCR test were performed, both of which were negative, and the patient was discharged home. The patient returned 3 days later for persistent intermittent fever and diarrhea and was admitted. An infectious disease panel was notable for positive SARS-CoV-2 IgG.

Erythrocyte sedimentation rate and C-reactive protein were elevated at 30 mm/hr and 325.0 mg/L, respectively. Complete blood count was notable for reduced hemoglobin (12.0 g/dL), hematocrit (35.4%), and platelets (57 K). During his hospital stay, he developed shock, hypotension, hypercoagulability, hyponatremia, acute kidney failure, and acute respiratory failure. EKG showed 1 st degree AV block, and repeat echocardiograms showed coronary artery dilation and systolic dysfunction indicative of myocarditis. The patient was diagnosed with MIS-C and managed with intravenous immunoglobulin, IV hydrocortisone, and enoxaparin. 

In this report, we describe a pediatric patient presenting with bilateral optic nerve edema and a concurrent right abducens nerve palsy related to increased intracranial pressure in the setting of COVID-19-associated Kawasaki-like inflammation, MIS-C. Whereas previous studies have focused on the more anterior ocular manifestations of COVID-19 in adults 4 and children, 5 this case demonstrates neurologic complications of COVID-19-associated MIS-C. This case is, to the best of our knowledge, only the third reported with elevated intracranial pressure and papilledema with abducens nerve palsy, 1,2 and the first to include fundus images.

Though the precise etiology of the increased intracranial pressure remains unclear, it is likely to be a contributing factor to the ocular and neurologic deficits observed in this MIS-C patient.

Lumbar puncture was ultimately not attained and elevated opening pressure could not be confirmed due to the confounding impact of the patient's immunoglobulin therapy and the resolution of his symptoms. However, the patient's constellation of papilledema, abducens nerve palsy, and headaches are consistent with literature reports of elevated intracranial pressure in patients with MIS-C.

Familiarity with MIS-C ocular presentations can better inform patient care as the COVID-19 pandemic continues to spread at an alarming pace among the pediatric population. Awareness of the ocular and neurologic manifestations of MIS-C is important in recognizing the syndrome quickly, and neurologic complaints of visual disturbances, headache, and ocular movement abnormality should raise suspicion for increased intracranial pressure and possible MIS-C. In patients with these symptoms, a dilated fundus examination may be of benefit.

None. 

Increased Intracranial Pressure in the Setting of Multisystem Inflammatory Syndrome in Children, Associated With COVID-19

Intracranial hypertension in multisystem inflammatory syndrome in children (MIS-C)

COVID-19 and Kawasaki disease: novel virus and novel case

Characteristics of Ocular Findings of Patients With Coronavirus Disease

Ocular Manifestations and Clinical Characteristics of Children With Laboratory-Confirmed COVID-19 in Wuhan, China

The authors would like to acknowledge Dr. Adam Baim for the optic disc photos.

This work was supported by an unrestricted grant to the Washington University in St. Louis Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness.